Calcineurin-mediated hippocampal inflammatory alterations in streptozotocin-induced model of dementia
JPA Dos Santos, AF Vizuete, CA Gonçalves - Molecular Neurobiology, 2020 - Springer
Although the pathogenesis of Alzheimer's disease (AD) remains unclear, some molecular
aspects that precede or accompany the deposit of β-amyloid in senile plaques attract …
aspects that precede or accompany the deposit of β-amyloid in senile plaques attract …
Proteolysis of calcineurin is increased in human hippocampus during mild cognitive impairment and is stimulated by oligomeric Abeta in primary cell culture
H Mohmmad Abdul, I Baig, H LeVine 3rd… - Aging cell, 2011 - Wiley Online Library
Recent reports demonstrate that the activation and interaction of the protease calpain (CP)
and the protein phosphatase calcineurin (CN) are elevated in the late stages of Alzheimer's …
and the protein phosphatase calcineurin (CN) are elevated in the late stages of Alzheimer's …
Interleukin-1β-dependent signaling between astrocytes and neurons depends critically on astrocytic calcineurin/NFAT activity
MA Sama, DM Mathis, JL Furman, HM Abdul… - Journal of Biological …, 2008 - ASBMB
Interleukin-1β (IL-1β) and the Ca 2+/calmodulin-dependent protein phosphatase,
calcineurin, have each been shown to play an important role in neuroinflammation …
calcineurin, have each been shown to play an important role in neuroinflammation …
Beta-amyloid causes downregulation of calcineurin in neurons through induction of oxidative stress
Calcineurin is an abundant cytosolic protein that is implicated in the modulation of glutamate
release. Here we show that the expression level of this enzyme is reduced in primary …
release. Here we show that the expression level of this enzyme is reduced in primary …
[HTML][HTML] Neuroimmunomodulation by calcineurin in aging and Alzheimer's disease
LC Reese, G Taglialatela - Aging and disease, 2010 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is a progressive, age-related neurodegenerative disorder which
first manifests as profound memory dysfunction. The majority of cases are idiopathic …
first manifests as profound memory dysfunction. The majority of cases are idiopathic …
Inhibition of the NFAT pathway alleviates amyloid beta neurotoxicity in a mouse model of Alzheimer's disease
E Hudry, HY Wu, M Arbel-Ornath… - Journal of …, 2012 - Soc Neuroscience
Amyloid β (Aβ) peptides, the main pathological species associated with Alzheimer's disease
(AD), disturb intracellular calcium homeostasis, which in turn activates the calcium …
(AD), disturb intracellular calcium homeostasis, which in turn activates the calcium …
Truncation and activation of calcineurin A by calpain I in Alzheimer disease brain
A disturbance of calcium homeostasis is believed to play an important role in the
neurodegeneration of the brains of Alzheimer disease (AD) patients, but the molecular …
neurodegeneration of the brains of Alzheimer disease (AD) patients, but the molecular …
Overactivation of calcineurin induced by amyloid-beta and prion proteins
P Agostinho, JP Lopes, Z Velez, CR Oliveira - Neurochemistry international, 2008 - Elsevier
Amyloid-beta protein (Aβ) and the scrapie isoform of prion protein (PrPSs) have a central
role in the pathogenesis of Alzheimer's disease (AD) and prion-related encephalopathies …
role in the pathogenesis of Alzheimer's disease (AD) and prion-related encephalopathies …
Inhibition of calcineurin by infusion of CsA causes hyperphosphorylation of tau and is accompanied by abnormal behavior in mice
D Yu, J Luo, F Bu, G Song, L Zhang, Q Wei - 2006 - degruyter.com
Calcineurin is a Ca2+/calmodulin-dependent phosphatase that dephosphorylates numerous
substrates in different neuronal compartments. Genetic and pharmacological studies have …
substrates in different neuronal compartments. Genetic and pharmacological studies have …
Calcineurin triggers reactive/inflammatory processes in astrocytes and is upregulated in aging and Alzheimer's models
CM Norris, I Kadish, EM Blalock, KC Chen… - Journal of …, 2005 - Soc Neuroscience
Astrocyte reactivity (ie, activation) and associated neuroinflammation are increasingly
thought to contribute to neurodegenerative disease. However, the mechanisms that trigger …
thought to contribute to neurodegenerative disease. However, the mechanisms that trigger …